(Q54177981)
Statements
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. (English)
Darragh Duffy
Eric Jeziorski
Laureline Berteloot
Marie-Louise Frémond
Nadia Jeremiah
Didier Bessis
Guilhem Cros
Gillian I Rice
Bruno Charbit
Anne Hulin
Nihel Khoudour
Consuelo Modesto Caballero
Christine Bodemer
Monique Fabre
Muriel Le Bourgeois
Philippe Reix
Stéphane Blanche
Alain Fischer
Bénédicte Neven
20 August 2016
138
6
1752-1755